Dietary Wheat Amylase Trypsin Inhibitors Worsen Chronic Liver Disease in Pre-Clinical Models of Nash and Liver Fibrosis

被引：0
|
作者：
Khan, Muhammad Ashfag, Jr. [1 ,2 ]
Aslam, Misbah, Jr. [1 ,2 ,3 ]
Senkowski, Marcel Sacha, Jr. [1 ,2 ]
Qureshi, Muhammad Asif [1 ,2 ]
Weng, Shih Yen [1 ,2 ]
Kim, Yong Ook [1 ,2 ]
Schattenberg, Jorn M. [4 ]
Schuppan, Detlef [1 ,2 ,5 ]
机构：
[1] Univ Med Ctr Mainz, Inst Translat Immunol, Mainz, Germany
[2] Univ Med Ctr Mainz, Res Ctr Immunotherapy, Mainz, Germany
[3] Shaheed Benazir Bhutto Women Univ, Peshawar, KP, Pakistan
[4] Univ Med Ctr Mainz, Dept Med, Mainz, Germany
[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1811
引用
收藏
页码：1028A / 1029A
页数：2
相关论文
共 50 条
  • [1] Common dietary component, wheat amylase trypsin inhibitors, driver of chronic liver disease in pre-clinical models of NASH and liver fibrosis
    Ashfaq-Khan, Muhammad
    Aslam, Misbah
    Qureshi, Asif
    Senkowski, Marcel
    Weng, Shih Yeng
    Kim, Yong Ook
    Schuppan, Detlef
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E518 - E519
  • [2] Dietary wheat amylase trypsin inhibitors activate myeloid cell toll-like receptor 4 to enhance chronic liver disease in murine liver fibrosis and hepatocellular carcinoma
    Ashfaq-Khan, Muhammad
    Aslam, Misbah
    Senkowski, Marcel
    Kim, Yong Ook
    Schuppan, Detlef
    JOURNAL OF HEPATOLOGY, 2020, 73 : S520 - S521
  • [3] Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease
    Muhammad Ashfaq-Khan
    Misbah Aslam
    Muhammad Asif Qureshi
    Marcel Sascha Senkowski
    Shih Yen-Weng
    Susanne Strand
    Yong Ook Kim
    Geethanjali Pickert
    Jörn M. Schattenberg
    Detlef Schuppan
    Scientific Reports, 9
  • [4] Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease
    Ashfaq-Khan, Muhammad
    Aslam, Misbah
    Qureshi, Muhammad Asif
    Senkowski, Marcel Sascha
    Yen-Weng, Shih
    Strand, Susanne
    Kim, Yong Ook
    Pickert, Geethanjali
    Schattenberg, Joern M.
    Schuppan, Detlef
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Dietary Wheat Alpha-Amylase-Trypsin Inhibitors (ATIS) Worsen Intestinal Inflammation in Mice
    Pickert, Geethanjali
    Heck, Rosario
    Weigert, Andreas
    Schuppan, Detlef
    GASTROENTEROLOGY, 2015, 148 (04) : S720 - S720
  • [6] WHEAT AMYLASE TRYPSIN INHIBITORS (ATI) PROMOTE LIVER FIBROSIS IN A MURINE MODEL OF PRIMARY SCLEROSING CHOLANGITIS FIBROSIS
    Khan, Muhammad Ashfaq, Jr.
    Aslam, Misbah, Jr.
    Senkowski, Marcel S.
    Schuppan, Detlef
    HEPATOLOGY, 2019, 70 : 1125A - 1125A
  • [7] Nutritional Wheat Alpha-Amylase Trypsin Inhibitors (ATIS) Synergize With a High Fat Diet to Worsen Non-Alcoholic Fatty Liver Disease
    Khan, Muhammad A.
    Wang, Xiao-Yu
    Weng, Shih Y.
    Zevallos, Victor F.
    Kim, Yong Ook
    Schuppan, Detlef
    GASTROENTEROLOGY, 2015, 148 (04) : S1056 - S1056
  • [8] Multimodal pre-clinical imaging of liver inflammation and fibrosis
    Schmidt-Christensen, Anja
    Nilsson, Julia
    Mayans, Sofia
    Holmberg, Dan
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E316 - E316
  • [9] EFFECT OF NUTRITIONAL WHEAT AMYLASE TRYPSIN INHIBITORS ON THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Khan, M. A.
    Aslam, M.
    Zevallos, V.
    Kim, Y. O.
    Wang, X.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S680 - S681
  • [10] Calpain Inhibition as Anti-Fibrotic Therapy: Discovery and Pre-Clinical Evaluation of Novel Inhibitors in Models of Lung and Liver Fibrosis
    Buckman, B.
    Schaefer, C. J.
    Kossen, K.
    Misialek, S.
    Lim, S. R.
    Arfsten, A.
    Kim, M.
    Wong, C.
    Wang, J. X.
    Ibrahim, P.
    Yu, W.
    Fuentes, M.
    Robbins, W.
    Emayan, K.
    Adler, M.
    Nicholas, J.
    Yuan, S.
    Ma, J.
    Kim, D.
    Ruhrmund, D.
    Rajagopalan, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345